Protectin D1 (Synonyms: Neuroprotectin D1, NPD1, PD1) |
Katalog-Nr.GC40981 |
Protectin D1, Neuroprotectin D1, wenn es von neuralen Zellen erzeugt wird, ist ein Mitglied einer neuen Familie bioaktiver Produkte, die aus DocosahexaensÄure erzeugt werden.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 660430-03-5
Sample solution is provided at 25 µL, 10mM.
Protectin D1 is a specialized pro-resolving mediator (SPM) synthesized from docosahexaenoic acid . DHA is oxidized to 16S,17S-epoxy-protectin, which is converted to protectin D1 enzymatically. Protectin D1 increases phagocytosis of apoptotic polymorphonuclear leukocytes (PMNs) by macrophages in a non-phlogistic manner and is generated in vitro during macrophage-apoptotic interactions. It enhances phagocytosis in mice after 24 hours, but not at the initiation or peak of inflammation. It also decreases PMN infiltration in a zymosan-induced mouse model of inflammation when administered at a dose of 300 ng per animal. Protectin D1 (200 µg, i.v.) inhibits increases in neutrophil counts in bronchoalveolar fluid (BALF) and lung myeloperoxidase activity in a mouse model of pulmonary injury and inflammation induced by intratracheal LPS instillation. It also decreases pulmonary edema and promotes neutrophil apoptosis in BALF.
Average Rating: 5
(Based on Reviews and 2 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *